Advanced Proteome Therapeutics Corporation (APTCF) 是一家上市公司 属于 医疗保健 板块，经营于 生物科技 行业. 公司总部位于 Burnaby, BC, 加拿大. 现任CEO为 Benjamin Krantz.
APTCF 拥有 IPO日期为 2009-07-10, 在 Other OTC, 市值为 $149.63K.
Advanced Proteome Therapeutics Corporation, through its subsidiary, Advanced Proteome Therapeutics Inc., operates as a biotechnology company in the United States. The company develops and commercializes a platform for the chemical modification of protein therapeutics. Its platform is dedicated to applications in the field of antibody drug conjugates, as well as focused on protein conjugates and immunomodulation. The company is headquartered in Burnaby, Canada.
